Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Ascendis' Hypoparathyroidism Drug Scores FDA Approval As First and Only Treatment, Replacing Takeda's Drug Discontinued Due To Supply Issues
August 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
ASND
TAK
New Study Reveals How Classical Music Could Revolutionize Depression Care
August 12, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
AXSM
BIIB
NBIX
Alzamend Neuro Partners with Massachusetts General Hospital for Phase II Trial of Next-Generation Treatment for Major Depressive Disorder
August 12, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Electrically Altering Children’s Brains: Psychiatry’s Latest Treatment Fad
August 12, 2024
Via
Press Release Distribution Service
Exposures
Product Safety
Hautuki Introduces Safe and Easy Supplements: Skin-Friendly, Hassle-Free Patch Solutions
August 09, 2024
Via
AB Newswire
Exposures
Product Safety
Electrically Altering Children's Brains: Psychiatry's Latest Treatment Fad
August 12, 2024
Via
PRLog
Exposures
Product Safety
Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder
August 12, 2024
Via
PressReach
Exposures
Product Safety
Tickers
ALZN
Ascendis Pharma Zips Higher After FDA Approves Embattled Thyroid Drug
August 12, 2024
Via
Investor's Business Daily
Exposures
Product Safety
Tickers
ASND
Delay Hits Humacyte's Bioengineered Human Tissue Implant For Vascular Trauma Injuries, FDA Extends Time To Review
August 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
HUMA
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
August 12, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SCPH
Hautuki, Safe and Easy Supplements: Gentle on Skin, Hassle-Free Patch
August 09, 2024
Via
AB Newswire
Exposures
Product Safety
The Cancer Battle - How Smaller Companies Are Making Big Advancements in Treatments for Solid Tumors
August 12, 2024
Via
Newsfile
Exposures
Product Safety
Tickers
AEMD
NVS
Adaptimmune Reports Q2 2024 Financial and Business Updates
August 12, 2024
Via
Newsfile
Exposures
Product Safety
Tickers
ADAP
FDA Breakthrough Device That Can Reverse Alzheimer’s Cognitive Decline May Well Increase Human Life Span
August 12, 2024
Via
Get News
Exposures
Product Safety
FDA Rejects MDMA For PTSD Treatment, Calls For More Research On Psychedelic Therapy
August 10, 2024
Via
Benzinga
Exposures
Product Safety
American Kratom Association Welcomes the FDA Withdrawal of Deeply Flawed Risk/Safety Data Collection and Study on Psychedelic and Kratom Use
August 09, 2024
Via
EZ Newswire
Exposures
Product Safety
FDA Poised To Make Historic Decision On MDMA Therapy To Treat PTSD: Here's How Things Stand
August 09, 2024
Via
Benzinga
Exposures
Product Safety
FDA Approves ARS Pharma's Once Rejected Neffy Nasal Spray Alternative To EpiPen For Emergency Allergy Treatment
August 09, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
SNY
SPRY
Analysis Shows Recalls Woefully Slow in Removing Potentially Contaminated Cannabis from Circulation
August 09, 2024
Via
CannabisNewsWire
Topics
Cannabis
Product Recall
Exposures
Cannabis
Legal
Product Safety
Tickers
VRNOF
Analysis Shows Recalls Woefully Slow in Removing Potentially Contaminated Cannabis from Circulation
August 09, 2024
Via
Investor Brand Network
Topics
Cannabis
Product Recall
Exposures
Cannabis
Legal
Product Safety
Anaheim White House Celebrates 37th Anniversary With Free Prosecco August 21
August 08, 2024
Via
Press Release Distribution Service
Topics
Economy
Product Recall
Exposures
Economy
Legal
Product Safety
Penny Stock Citius Pharmaceuticals Secures Its First FDA Approval For Skin Cancer Drug A Year After FDA Rejection
August 08, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
CTXR
Emerging Giants: AI-Driven Innovators Under $2 Set to Transform Markets INBS, PRSO, LPSN, PACB, NINE
August 08, 2024
Via
AB Newswire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Product Safety
Tickers
INBS
PRSO
Why Choose Capsule Tablet Metal Detector in Pharmaceutical Industry?
August 08, 2024
Via
AB Newswire
Topics
Product Recall
Exposures
Legal
Product Safety
FDA Approves Expanded Use Of Novartis' Rare Disease Drug Fabhalta For Kidney Disease
August 08, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
NVS
JD.JUNE’s Bodysuits for Bosses: Revolutionizes Corporate America
August 08, 2024
Via
Syndication Cloud
Topics
Product Recall
Exposures
Legal
Product Safety
BMW Recalls Over 105K Vehicles In U.S. Over Fire Risks Due To Overheating Starter Motor
August 08, 2024
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Tickers
BMWYY
3 Biotech Stocks With Promising Drug Pipelines: August 2024
August 08, 2024
Via
InvestorPlace
Exposures
Product Safety
Tickers
BMY
BNTX
REGN
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Analyst Sees Exelixis At Inflection Point Despite Mixed Trial Results
August 07, 2024
Via
Benzinga
Exposures
Product Safety
Tickers
EXEL
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.